Inari Medical, Inc. - Common Stock (NQ:NARI)

79.97 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inari Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Inari Medical Reports Third Quarter 2024 Financial Results

October 28, 2024

From Inari Medical, Inc.

Via GlobeNewswire

Inari Medical's Earnings: A Preview ↗

October 25, 2024

Via Benzinga

Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial

October 15, 2024

From Inari Medical, Inc.

Via GlobeNewswire

Breaking Down Inari Medical: 9 Analysts Share Their Views ↗

October 09, 2024

Via Benzinga

Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation

October 07, 2024

From Inari Medical, Inc.

Via GlobeNewswire

Expert Outlook: Inari Medical Through The Eyes Of 9 Analysts ↗

September 17, 2024

Via Benzinga

Breaking Down Inari Medical: 7 Analysts Share Their Views ↗

August 26, 2024

Via Benzinga

Inari Medical to Announce Third Quarter 2024 Financial Results

October 07, 2024

From Inari Medical, Inc.

Via GlobeNewswire

Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Investors to Contact the Firm

September 17, 2024

From Kaskela Law LLC

Via Business Wire

Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024

August 29, 2024

From Inari Medical, Inc.

Via GlobeNewswire

FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious ↗

August 26, 2024

The FDA labels Inari Medical's ClotTriever catheter recall as the most serious, citing risks like device entrapment and pulmonary emboli, linked to injuries and deaths.

Via Benzinga

Deep Dive Into Inari Medical Stock: Analyst Perspectives (5 Ratings) ↗

July 16, 2024

Via Benzinga

Inari Medical to Present at Upcoming Investor Conferences

August 21, 2024

From Inari Medical, Inc.

Via GlobeNewswire

7 Leading MedTech Stocks for Next-Gen Health Solutions ↗

July 31, 2024

With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.

Via InvestorPlace

NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q2 2024 ↗

July 30, 2024

NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Inari Medical Announces Chief Financial Officer Retirement and Succession Plan

July 30, 2024

Mitch Hill to retire as Chief Financial Officer, to be succeeded by Kevin Strange in October 2024

From Inari Medical, Inc.

Via GlobeNewswire

Inari Medical Reports Second Quarter 2024 Financial Results

July 30, 2024

From Inari Medical, Inc.

Via GlobeNewswire

Inari Medical to Announce Second Quarter 2024 Financial Results

July 16, 2024

From Inari Medical, Inc.

Via GlobeNewswire

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari

July 12, 2024

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inari To Contact Him Directly To Discuss Their Options

From Faruqi & Faruqi LLP

Via GlobeNewswire

NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 12, 2024

From Schall Law

Via GlobeNewswire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inari Medical, Inc. (NARI)

July 11, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 11, 2024

From The Schall Law Firm

Via Business Wire

NARI Investors Have the Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 10, 2024

From The Schall Law Firm

Via Business Wire

INARI MEDICAL 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI

July 09, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 09, 2024

From Schall Law

Via GlobeNewswire

NARI Investors Have the Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 08, 2024

From The Schall Law Firm

Via Business Wire

Inari Medical, Inc. INVESTOR ALERT: Kirby McInerney LLP Alerts Inari Medical, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit

July 05, 2024

From Kirby McInerney LLP

Via Business Wire

ROSEN, A LEADING NATIONAL FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI

July 03, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 02, 2024

From Schall Law

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sprout Social, Inari, UnitedHealth, and Vestis and Encourages Investors to Contact the Firm

June 30, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.